ORPHAZYME A/S - ADR (ORPH) Stock Analyst Earnings Estimates
NASDAQ:ORPH - Nasdaq - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -37.14% | N/A 204.55% | N/A 78.35% | N/A 83.70% | |||||||
| EBITDA YoY % growth | -29.236M | -62.814M -114.85% | -130.415M -107.62% | -230.286M -76.58% | -332.151M -44.23% | -603.334M -81.64% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -29.522M | -63.52M -115.16% | -131.042M -106.30% | -231.652M -76.78% | -335.954M -45.03% | -608.534M -81.14% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A -67.59% | N/A -25.87% | N/A -14.75% | N/A 18.09% | N/A -46.73% | N/A -0.41% | N/A 25.80% | N/A 23.57% |
| Q3 / 21 | Q4 / 21 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -3.86 | -3.65 81.47% | -9.48 -159.89% |
| Revenue Q2Q % growth | 307.545M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | -20.89% | -19.67 | % |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in DKK, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |